Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Cloning And Expression Of Malaria And Tuberculosis Epitopes In Mycobacterium Bovis Bacille Calmette-Guerin.

Rapeah Suppian, and Zainul Fadziruddin Zainuddin, and Mohd. Nor Norazmi, (2006) Cloning And Expression Of Malaria And Tuberculosis Epitopes In Mycobacterium Bovis Bacille Calmette-Guerin. Malaysian Journal of Medical Sciences, 13 (1). pp. 13-20. ISSN 1394195X

Full text not available from this repository.

Official URL: http://www.medic.usm.my/publication/mjms/

Affiliations

Universiti Sains Malaysia, School of Health Sciences

Abstract

Mycobacterium bovis bacille Calmette-Guèrin (BCG)represents one of the most promising live vectors for the delivery of foreign antigens to the immune system. A recombinant BCG containing a synthetic gene coding for the malarial epitopes namely, the fragment 2 of region II of EBA-175 (F2R(II)EBA) and the repeat sequence of the circumsporozoite protein NANP generated in favour of mycobacterium codon usage using assembly PCR was constructed. Two T-cell epitopes of the 6-kDa M. tuberculosis early–secreted antigenic target (ESAT-6)
antigen were also clone in the same construct. Expression of the synthetic gene was driven by the heat shock protein 65 (hsp65) promoter from M. tuberculosis and the signal peptide from the MPT63 antigen of M. tuberculosis. Expression of the composite epitopes was detected by Western blotting of the cell extract and culture supernatant of the recombinant clones using a specific rabbit polyclonal antibody against F2R(II)EBA. This study demonstrates the possibility of cloning and expressing immunogenic epitopes from causative agents of two important
diseases: malaria and tuberculosis (TB) in a single recombinant BCG construct.

Item Type:Journal
Keywords:Assembly PCR, malaria, multivalent vaccine, recombinant BCG, tuberculosis.
Subjects:R Medicine
ID Code:810

1. World Health Organization. World malaria situation in 1994. Weekly Epidem Rec 1997; 72: 269-74.

2. Good M.F, Kaslow D.C, Miller L.H. Pathway and strategies for developing a malaria blood stage vaccine. Ann Rev Immunol 1998; 16: 57-87.

3. Raghunath D. Malaria vaccine: Are we anywhere close?. J Postgrad Med 2004; 50: 51-4.

4. Phillips R.S. Current status of malaria and potential for control. Clin Microbiol Rev 2001; 14: 208-26.

5. Dye D, Scheele S, Dolin P, Tathania V, Raviglione, M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO global surveillance and monitoring project. J Am Med Assoc 1999; 282: 677-86.

6. Fine P.F. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.

7. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004; 84: 93-101.

8. Espinal M.A, Laszlo A, Simonsen L, Boulahbal F, Kim S.J, Reniero A, Hoffner S, Rieder H.L, Binkin N, Dye C, Williams R, Raviglione M.C. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-303.

9. Frieden C.R, Sterling A, Pablos-Mendez J, Kilburn J.O, Cauthen G.M, Dooley S.W. The emergence of drugresistant tuberculosis in New York City. N Eng J Med 1993; 328:521-6.

10. Horwitz M.A, Harth G, Dillon B.J, Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000; 97:13853-8.

11. Husson R.N, James B.E, Young R.A. Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 1991; 172: 519-24.

12. Stover C.K, de la Cruz V.F, Fuerst T.R, Burlein J.E, Benson L.A, Benett L.T, Bansal G.P, Young J.F, Lee M.H, Hatfull G.F, Snapper S.B, Barletta R.G, Jacobs W.R Jr, Bloom B.R. New use of BCG for recombinant vaccines. Nature 1991; 351:456-60.

13. Haeseleer F, Pollet J.F, Haumont M, Bollen A, Jacobs

P. Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence

in mycobacteria. Mol Biochem Parasitol 1993; 57: 117-26.

14. Matsumoto S, Yukitake H, Kanbara H, Yamada T. Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 1998; 188: 845-54.

15. Norazmi M.N, Dale J.W. Cloning and expression of a candidate malaria epitope in bacille Calmette Guèrin.

Biotech Letters 1997; 19: 1135-7.

16. Zheng C, Xie P, Chen Y. Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum. Vaccine 2001;20: 914-9.

17. Abomoelak B, Huygen K, Kremer L, Turneer M, Locht C. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis bacillus Calmette-Guèrin producing a pertussis toxintetanus toxin hybrid protein. Infect Immun 1999; 67:5100-5.

18. Aldovini A, Young R.A. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991; 351: 479-82.

19. Norazmi M.N, Zainuddin Z.F, Suppian R, Dale J.W. The use of assembly polymerase chain reaction for cloning of a malarial epitope into Mycobacterium smegmatisimportance

of overcoming codon bias. Biotech Techn 1999; 13: 485-9.

20. Liang H, Narum D.L, Fuhrmann S.R, Luu T, Sim B.K.L. A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. Infect Immun 2000; 68: 3564-8.

21. Sim B.K.L, Orlandi P.A, Haynes J.D, Klotz F.W, Carter J.M, Camus D, Zegans M.E, Chulay, J.D. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol 1990; 111: 1877-84.

22. Ballou W.R, Hoffman S.L, Sherwood J.A, Hollingdale M.R, Neva F.A, Hockmeyer W.T, Gordon D.M, Schneider I, Wirtz R.A, Young J.F, Waserman J.F, Reeve P, Diggs C.L, Chulay J.D. Safety and efficacy of recombinant Plasmodium falciparum sporozoite DNA vaccine. Lancet 1987; 1: 1277-81.

23. Zavala F, Cochrane A.H, Nardin E.H, Nussenzweig R.S, Nussenzweig V. Circumsporozoite proteins of malaria parasites contain a single imunodominant region with two or more identical epitopes. J Exp Med 1983; 157:1947-54.

24. Brandt L, Oettinger T, Holm A, Anderson A.B, Anderson P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996; 157: 3527-33.

25. van Pinxteren L.A, Ravn P, Agger E.M, Pollock J, Anderson P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7: 55-60.

26. Manca C, Lyashchenko K, Wiker H.G, Usai D, Colangeli R, Gennaro M.A. Molecular cloning,purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997; 65: 16-23.

27. Nangai S, Wiker H.G, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991; 59: 372-82.

28. Stemmer W.P.C, Crameri A, Ha K.D, Brennan T.M, Heynecker H.L. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 1995; 164: 49-53.

29. Rao V, Dhar N, Tyagi A.K. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacilli Calmette-Guérin. Scand J Immunol 2003; 58: 449-61.

30. Dale J.W, Patki A. Mycobcterial gene expression and regulation. In Mcfadden J, eds. Molecular Biology of Mycobacteria. Surrey, Surrey University Press, 1990;175-98.

31. Labidi A, David H.L, Roulland-Dussoix D. Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann Inst Pasteur Microbial 1985; 136: 209-15.

32. Bao L, Chen W, Zhang H, Wang X. Virulence, immunogenicity and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guèrin strain expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003; 71:1656-61.

33. Britton W.J, Palendira U. Improving vaccine against tuberculosis. Immunol Cell Biol 2003; 81: 34-45.

34. Whithers-Martinez C, Carpenter E.P, Hackett F, Ely B,

Sajid M, Grainger M, Blackman M.J. PCR-based gene synthesis as an efficient approach for expression of the A+T-rich malaria genome. Protein Engineering 1999; 12: 1113-20.

35. Narum, D.L, Kumar S, Rogers W.O, Fuhrmann S.R, Liang H, Oakley M, Taye A, Sim B.K.L, Hoffman S.L. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun 2001; 69: 7250-53.

Repository Staff Only: item control page
 
 
 
 
 
   
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.